Ivermite Tablets 6mg (Ivermectin)

• Registered with DRAP under number 061339. (DRAP registry entry)
• DRAP’s notified maximum price for the 10-tablet pack is Rs 595.62, effective 23 July 2026 (DRAP price index). We list it lower until we have read the price printed on our packs.
• DRAP also registers Ivermite Lotion 0.5% (110068) to Atco Laboratories, a separate registration for use on the skin. It is not this product.
• We dispense it on prescription: the right amount depends on body weight and on which parasite is being treated, which needs a diagnosis.

Scabies in the US: “Oral ivermectin is not FDA approved for the treatment of scabies” (CDC, clinical care of scabies). The FDA says that, “with few exceptions”, doctors may prescribe an approved medicine for an unapproved use when they judge it medically appropriate for a patient.

The US label is for 3 mg tablets. The 6 mg Stromectol tablet is discontinued in the US; Drugs@FDA records that it was not withdrawn for safety or effectiveness reasons.

The alert numbers are taken from the alert documents themselves (I/S/11-25-111, I/S/03-26-24). DRAP’s web listing of those alerts shows different numbers for these two, I/S/10-25-111 and I/S/04-26-24; we follow the documents, which the listing indexes.

• Warning: “Animal ivermectin products are different formulations than those approved for humans. Due to the lack of testing of these formulations in humans, the safety of these products in humans is not known.” (US FDA)
• Warning: “The FDA has received multiple reports of patients who have required medical attention, including hospitalization, after self-medicating with ivermectin intended for animals.” (US FDA)
• Warning: An ivermectin overdose “can cause nausea, vomiting, diarrhea, hypotension (low blood pressure), allergic reactions (itching and hives), dizziness, ataxia (problems with balance), seizures, coma and even death.” (US FDA)
• People exposed to veterinary ivermectin, by mouth, breathing it in, injection or on the skin, most often reported rash, swelling, headache, dizziness, weakness, nausea, vomiting and diarrhoea; seizures and problems with balance and breathing were also reported (US FDA label for Stromectol (Merck), revised 09/2024, overdosage).

• Warning: Do not take it if you are allergic to any ingredient (the label’s only contraindication).
• Warning: If you may have loiasis (Loa loa infection): people with onchocerciasis who are also heavily infected with Loa loa may rarely develop a serious or fatal brain disorder (encephalopathy). The label calls for assessment for loiasis before treatment in anyone who has had significant exposure to areas of West or Central Africa where Loa loa is found.
• Warning: Nervous system effects, including drowsiness, confusion, disorientation, stupor, coma and death, have been reported, including in people without onchocerciasis.
• People with onchocerciasis can have skin, joint, lymph node and fever reactions as the parasites die (the Mazzotti reaction), and eye reactions too.
• A weakened immune system, including HIV: strongyloidiasis may need repeated courses, and cure may not be achievable.
• Older people: treatment should be cautious, because of more frequent liver, kidney or heart problems and other medicines.